CD4 and carcinoma of esophagus: Therefore, our study suggests that the reduced expression of FOXP1 in oesophageal squamous cell carcinoma may lead to downregulation of CD4+ T cells and B cells, promoting immune escape of tumour cells and progression of oesophageal cancer.